Suppr超能文献

-GlcNAcylation 减少自发性高血压大鼠近端小管蛋白重吸收并促进蛋白尿。

-GlcNAcylation reduces proximal tubule protein reabsorption and promotes proteinuria in spontaneously hypertensive rats.

机构信息

Instituto de Biofísica Carlos Chagas Filho, Universidade Federal do Rio de Janeiro, Rio de Janeiro 21949-900, Brazil.

Programa de Desenvolvimento de Fármacos, Instituto de Ciências Biomédicas, Universidade Federal do Rio de Janeiro, Rio de Janeiro 21941-902, Brazil.

出版信息

J Biol Chem. 2018 Aug 17;293(33):12749-12758. doi: 10.1074/jbc.RA118.001746. Epub 2018 Jun 28.

Abstract

Hypertensive individuals are at greater risk for developing chronic kidney disease (CKD). Reducing proteinuria has been suggested as a possible therapeutic approach to treat CKD. However, the mechanisms underlying the development of proteinuria in hypertensive conditions are incompletely understood. Cardiac and vascular dysfunction is associated with changes in the -GlcNAcylation pathway in hypertensive models. We hypothesized that -GlcNAcylation is also involved in renal damage, especially development of proteinuria, associated with hypertension. Using the spontaneously hypertensive rat (SHR) model, we observed higher renal cortex -GlcNAcylation, glutamine-fructose aminotransferase (GFAT), and -GlcNAc transferase (OGT) protein expression, which positively correlated with proteinuria. Interestingly, this was observed in hypertensive, but not pre-hypertensive, rats. Pharmacological inhibition of GFAT decreased renal cortex -GlcNAcylation, proteinuria, and albuminuria in SHR. Using a proximal tubule cell line, we observed that increased -GlcNAcylation reduced megalin surface expression and albumin endocytosis , and the effects were correlated Moreover, megalin is -GlcNAcylated both and In conclusion, our results demonstrate a new mechanism involved in hypertension-associated proteinuria.

摘要

高血压个体发生慢性肾脏病(CKD)的风险更高。减少蛋白尿已被认为是治疗 CKD 的一种可能的治疗方法。然而,高血压情况下蛋白尿发展的机制尚不完全清楚。心脏和血管功能障碍与高血压模型中 -GlcNAc 化途径的变化有关。我们假设 -GlcNAc 化也参与了与高血压相关的肾脏损伤,特别是蛋白尿的发展。使用自发性高血压大鼠(SHR)模型,我们观察到肾脏皮质 -GlcNAc 化、谷氨酰胺果糖氨基转移酶(GFAT)和 -GlcNAc 转移酶(OGT)蛋白表达增加,这与蛋白尿呈正相关。有趣的是,这仅在高血压而非高血压前期大鼠中观察到。GFAT 的药理学抑制降低了 SHR 的肾脏皮质 -GlcNAc 化、蛋白尿和白蛋白尿。使用近端肾小管细胞系,我们观察到 -GlcNAc 化增加会降低 megalin 的表面表达和白蛋白内吞作用,并且这些作用呈相关性。此外,megalin 既在 位点又在 位点被 -GlcNAc 化。综上所述,我们的研究结果表明了一种与高血压相关蛋白尿相关的新机制。

相似文献

2
Cardiac O-GlcNAc signaling is increased in hypertrophy and heart failure.心脏 O-GlcNAc 信号在肥大和心力衰竭中增加。
Physiol Genomics. 2012 Feb 1;44(2):162-72. doi: 10.1152/physiolgenomics.00016.2011. Epub 2011 Nov 29.
10
Role of O-linked N-acetylglucosamine modification in diabetic nephropathy.O-连接的N-乙酰葡糖胺修饰在糖尿病肾病中的作用。
Am J Physiol Renal Physiol. 2016 Dec 1;311(6):F1172-F1181. doi: 10.1152/ajprenal.00545.2015. Epub 2016 Mar 30.

引用本文的文献

1
Glycosylation in kidney diseases.肾脏疾病中的糖基化作用。
Precis Clin Med. 2025 Jul 11;8(3):pbaf017. doi: 10.1093/pcmedi/pbaf017. eCollection 2025 Sep.
4
Megalin: A Sidekick or Nemesis of the Kidney?巨蛋白:肾脏的帮手还是克星?
J Am Soc Nephrol. 2025 Feb 1;36(2):293-300. doi: 10.1681/ASN.0000000572. Epub 2024 Nov 15.
5
Handling the sugar rush: the role of the renal proximal tubule.应对血糖急升:近端肾小管的作用
Am J Physiol Renal Physiol. 2024 Dec 1;327(6):F1013-F1025. doi: 10.1152/ajprenal.00265.2024. Epub 2024 Oct 24.

本文引用的文献

7
N-Glycoform-dependent interactions of megalin with its ligands.巨胞饮受体与其配体的 N-糖型依赖性相互作用。
Biochim Biophys Acta Gen Subj. 2017 Jan;1861(1 Pt A):3106-3118. doi: 10.1016/j.bbagen.2016.10.015. Epub 2016 Oct 20.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验